New IV drug shows promise for kids with stubborn arthritis
NCT ID NCT02277444
First seen Nov 15, 2025 · Last updated May 08, 2026 · Updated 19 times
Summary
This study tested a drug called golimumab in 130 children with active juvenile idiopathic arthritis that did not improve with methotrexate. The drug is given through a vein and works by blocking a protein that causes inflammation. The main goal was to see how the drug moves through the body and to check its safety over 52 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, JUVENILE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
San Diego, California, United States
-
Study site
Chicago, Illinois, United States
-
Study site
Boston, Massachusetts, United States
-
Study site
Hackensack, New Jersey, United States
-
Study site
New Hyde Park, New York, United States
-
Study site
Durham, North Carolina, United States
-
Study site
Hickory, North Carolina, United States
-
Study site
Avon, Ohio, United States
-
Study site
Cincinnati, Ohio, United States
-
Study site
Cleveland, Ohio, United States
-
Study site
Portland, Oregon, United States
-
Study site
Philadelphia, Pennsylvania, United States
-
Study site
Austin, Texas, United States
-
Study site
Salt Lake City, Utah, United States
-
Study site
Buenos Aires, Argentina
-
Study site
Rosario, Argentina
-
Study site
San Miguel de Tucumán, Argentina
-
Study site
Botucatu, Brazil
-
Study site
Campinas, Brazil
-
Study site
Porto Alegre, Brazil
-
Study site
Rio de Janeiro, Brazil
-
Study site
São Paulo, Brazil
-
Study site
Calgary, Alberta, Canada
-
Study site
Toronto, Ontario, Canada
-
Study site
Montreal, Quebec, Canada
-
Study site
Región Metropolitana de Santia, Chile
-
Study site
Haifa, Israel
-
Study site
Kfar Saba, Israel
-
Study site
Petah Tikva, Israel
-
Study site
Chihuahua City, Mexico
-
Study site
Guadalajara, Mexico
-
Study site
Mexico City, Mexico
-
Study site
Mosco2, Russia
-
Study site
Saint Petersburg, Russia
-
Study site
Saratov, Russia
-
Study site
Tolyatti, Russia
-
Study site
Ufa, Russia
-
Study site
Cape Town, South Africa
Conditions
Explore the condition pages connected to this study.